TP53 and neuroblastoma: Using an in vitro model of acquired drug resistance in neuroblastoma, van Maerken treated cells with nutlin-3 and saw a significant decrease in cell proliferation in cell lines with wild-type P53 but not in those with mutant P53 [64].